KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS - The Manila Times
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS The Manila Times
EXPRESSION OF CONCERN: Melatonin Protects Against Endometriosis via Regulation of Matrix Metalloproteinase-3 and an Apoptotic Pathway.
S. Paul, P. Bhattacharya, P. D. Mahapatra, and S. Swarnakar, "Melatonin Protects Against Endometriosis via Regulation of Matrix Metalloproteinase-3 and an Apoptotic Pathway," Journal of Pineal Research 49, no. 2 …